Filing Details
- Accession Number:
- 0001567619-20-004695
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-24 16:40:03
- Reporting Period:
- 2020-02-20
- Accepted Time:
- 2020-02-24 16:40:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1080014 | Innoviva Inc. | INVA | Pharmaceutical Preparations (2834) | 943265960 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1750085 | Marianne Zhen | 1350 Old Bayshore Highway, Suite 400 Burlingame CA 94010 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-02-20 | 2,073 | $15.10 | 24,867 | No | 4 | F | Direct | |
Common Stock | Disposition | 2020-02-24 | 2,954 | $14.78 | 21,913 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.
- This sale was effected for tax planning purposes.